Rubicon Research Ltd.

NSE: RUBICON | BSE: 544578 | ISIN: INE506V01022 | Industry: Pharmaceuticals
| Expensive Performer
1525.4000 59.00 (4.02%)
NSE Jul 23, 2026 15:31 PM
Volume: 526.8K
 

1525.40
4.02%
Motilal Oswal
Rubicon Research (Rubicon) delivered better-than-expected performance, with a 7%/18%/21% beat on revenue/EBITDA/PAT for the quarter.
Rubicon Research has gained 214.52% in the last 1 Year
More from Rubicon Research Ltd.
Recommended